Methylphenidate, lisdexamfetamine▼, dexamfetamine▼, guanfacine▼ & atomoxetine for Attention Deficit Hyperactivity Disorder in patients 6-18 yearsShared Care Guideline: Prescribing Agreement • November 10th, 2020
Contract Type FiledNovember 10th, 2020